| 英文别名 |
Prosta-5,8(12),13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-;PGB2 (Prostaglandin B2);Prostaglandin B2;Prostaglandin B2 Lipid Maps MS Standard;(5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,8(12),13-trien-1-oic acid PGB2;PGB2;PROSTAGLANDINS B2;prostaglandinb2crystalline;MYHXHCUNDDAEOZ-VLELWLJNSA-N;Prostaglandin B2 MaxSpecStandard;9-OXO-15S-HYDROXY-PROSTA-5Z,8(12),13E-TRIEN-1-OIC ACID;[5Z,13E,15S]-15-HYDROXY-9-OXOPROSTA-5,8[12],13-TRIEN-1-OIC ACID;HMS3402K06;HMS1361K06;MFCD00065730;NS00069893;UNII-BIU61O9T9T;CHEMBL1901620;J-006426;NCGC00161283-02;LMFA03010018;CS-0059421;NCGC00161283-01;DINOPROSTONE IMPURITY, (5Z,13E,15S)-15-HYDROXY-9-OXOPROSTA-5, 8(12),13-TRIEN-1-OIC ACID- [USP IMPURITY];HMS3648K17;PGB2-[d4];DB02304;Prosta-5,8(12),13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-;Prostaglandin B2, >=98%, synthetic;C05954;SCHEMBL3368055;BCBcMAP01_000173;Q27093323;15.ALPHA.-HYDROXY-9-KETOPROSTA-5,8(12),13-TRIENOIC ACID;(5Z,13E,15S)-15-HYDROXY-9-OXOPROSTA-5, 8(12),13-TRIEN-1-OIC ACID;BSPBio_001484;IDI1_033954;PRFXRIUZNKLRHM-HKVRTXJWSA-N;(Z)-7-[2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid;prostaglandin B2;HMS1989K06;BML1-F04;AKOS040755329;BIU61O9T9T;SR-01000946234-1;15S-hydroxy-9-oxo-5Z,8(12),13E-prostatrienoic acid;HY-113042;(Z)-7-(2-((E)-(3S)-3-HYDROXYOCT-1-ENYL)-5-OXOCYCLOPENT-1-ENYL)HEPT-5-ENOIC ACID;13367-85-6;CHEBI:28099;HMS1791K06;DTXSID50864391;DINOPROSTONE IMPURITY E [EP IMPURITY];prosta-glandinb2;(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,8(12),13-trien-1-oic acid;NCGC00161283-03;BRD-K82865713-001-02-6;(Z)-7-[2-[(E,3R)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid;15-HYDROXY-9-OXOPROSTA-5,8(12),13-TRIENOIC ACID;SR-01000946234;PROSTAGLANDIN B2 |
